Endocrinology Activities
Reducing the Risk of Cardiovascular Disease in Patients With Diabetes
0290-0000-18-081-H01-P
This activity presented by PTCE will focus on how newer antihyperglycemic medications can improve healthcare economics with the potential for reduction of cardiovascular disease.
3.00
Improving Outcomes in Diabetic Retinopathy: A Specialty Pharmacy Discussion of Outcomes and Cost- Effectiveness
0290-0000-18-145-H01-P
This program presented by PTCE will address the appropriate identification of risk factors for diabetic retinopathy, as well as diabetic macular edema (DME)
1.50
An American Journal of Managed Care Medical Crossfire®: Management of Newer Ultra–Long–Acting Basal Insulin Agents in Diabetes
0290-0000-18-017-H01-P
This Medical Crossfire will highlight the safety and efficacy data related to the newer generation, ultra–long-acting insulins and their place in therapy.
2.00
Evaluating New–Generation Basal Insulin Therapy
0290-0000-18-022-H01-P
This supplement will provide managed care professionals with an overview of diabetes, the status of diabetes control in the U.S., and related comorbidities.
2.50